July 2026
The sleep disorder market size was estimated at USD 31.79 billion in 2025 and is predicted to be worth around USD 94.82 billion by 2035 with a CAGR of 11.55%.
September 2026
The global circadian rhythm sleep disorders market size was evaluated at USD 2.90 billion in 2026 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The global sleep aids market size is expected to increase from USD 90.03 billion in 2026 and is projected to hit USD 173.68 billion by 2035 with a CAGR of 7.58%.
September 2026
The global post-traumatic stress disorder treatment market size is projected to hit around USD 3.55 billion by 2035 from USD 2.47 billion in 2026, with a CAGR of 4.12%.
September 2026
The global opioid use disorder market size is estimated to hit around USD 16.75 billion by 2035, increasing from USD 6.56 billion in 2026, with a CAGR of 11.00%.
September 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
September 2026
The global sleep monitoring devices market size is projected to hit around USD 116.08 billion by 2035 from USD 31.28 billion in 2026 with a solid CAGR of 15.79%.
September 2026
The autoimmune neurological disorders market generated USD 9.17 billion in 2026, with prominent autoimmune neurological disorders market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The global sleep apnea devices market size was valued at USD 7.62 billion in 2026 and is projected to hit around USD 14.00 billion by 2035 with a notable CAGR of 7.01%.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 128.39 billion in 2026 with a CAGR of 6.07%.
April 2026
The global sleep trackers market size was evaluated at USD 7.02 billion in 2025 and is predicted to hit around USD 18.37 billion by 2035, growing at a CAGR of 10.10%.
April 2026
The global hyperpigmentation disorder treatment market size is estimated to hit around USD 12.28 billion by 2035 increasing from USD 6.19 billion in 2025, with a CAGR of 7.09%.
February 2026
The global sleep tech devices market size was estimated at USD 29.30 billion in 2025 and is projected to surpass around USD 153.69 billion by 2035, with a CAGR of 18.03%.
February 2026
The global sleep aid supplements market size expected to increase from at USD 7.57 billion in 2025 and is predicted to hit USD 12.46 billion by 2035, growing at a CAGR of 5.11%.
December 2025
The global gastric motility disorder drug market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2025 to 2035.
July 2025
The global autism spectrum disorder treatment market size was valued at USD 2.64 billion in 2026 and is expected to hit around USD 4.22 billion by 2034, at a CAGR of 6.03%.
July 2025
The home sleep apnea testing devices market size is estimated to hit around USD 5,554.30 million by 2034 from USD 1,211.93 million in 2024 with a CAGR of 16.44%.
August 2025
The U.S. pantoprazole market size was evaluated at USD 743.96 million in 2024 and is predicted to hit around USD 1,302.87 million by 2034, growing at a CAGR of 5.76%.
August 2025
The global anti-thyroid peroxidase antibody test kit market size was valued at USD 150.07 million in 2024 and is expected to hit around USD 341.19 million by 2034, growing at a CAGR of 8.56%.
August 2025
The neurotech devices market size was valued at USD 14.75 billion in 2024 and is projected to worth around USD 55.79 billion by 2034 with a CAGR of 13.84%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com